This is interesting, and not in a good way. I'm not sure FDA as we know it can survive a two-track regime, where some medicine is fast tracked and/or cleared of

This is interesting, and not in a good way. I'm not sure FDA as we know it can survive a two-track regime, where some medicine is fast tracked and/or cleared of legal liability. Sooner or later most new medicine will end up on the fast track, it's in the logic of large bureaucratic bodies. https://arstechnica.com/science/2021/09/top-fda-regulators-blast-us-booster-plan-after-announcing-resignations https://arstechnica.com/science/2021/09/top-fda-regulators-b...